RL
Roshan Lalchand Jain
About Roshan Lalchand Jain
Data last updated:
Roshan Lalchand Jain is a Designated Partner at Shray Pharma Llp (since 2019), Director at Rrakov Exim Private Limited (since 2015) and Director at Ferro Strategic Solutions Private Limited (since 2024), and holds 3 more current directorships. The companies operate in Pharma, Chemicals and Paper. The largest current company by reported revenue is Shray Pharma Llp at ₹38.7 Lakh (FY 2022). Earlier, Roshan Lalchand Jain was a Director at Hestco Healthcare Private Limited (2023–2025) and Director at Vitalone Pharma Private Limited (2024–2025) and 8 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shray Pharma Llp AAQ-0576 | Designated Partner | 25 Jul 2019 | 2019 | ₹38.7 Lakh (FY 2022) | Active |
| Rrakov Exim Private Limited U46497MH2015PTC270279 | Director | 19 Nov 2015 | 2015 | Active | |
| Ferro Strategic Solutions Private Limited U46109MH2024PTC417922 | Director | 23 Jan 2024 | 2024 | Active | |
| Exemplus Healthcare Private Limited U21001MH2024PTC416536 | Director | 02 Jan 2024 | 2024 | Active | |
| Lebron Lifesciences Private Limited U46497MH2023PTC416039 | Director | 26 Dec 2023 | 2023 | Active | |
| Kera Bella Fashions Llp AAZ-0447 | Designated Partner | 04 Nov 2022 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Hestco Healthcare Private Limited U21000MH2023PTC413936 | Director | 18 Nov 2023 | 2023 | Active | |
| Vitalone Pharma Private Limited U21001MH2024PTC417146 | Director | 12 Jan 2024 | 2024 | Active | |
| Kera Fashions Llp AAV-1022 | Designated Partner | 15 Dec 2020 | 2020 | Active | |
 Maxwell Life Science Limited U24230MH2004PLC146536 | Director | 01 Jan 2019 | 2004 | ₹137 Cr (FY 2025) | Active |
| Pharex International Private Limited U74120MH2014PTC258517 | Director | 14 Sep 2015 | 2014 | Strike Off | |
| Snb India Lifestyles And Infra Llp AAR-4108 | Designated Partner | 25 Dec 2019 | 2019 | Active | |
| Raanan Advisory Llp AAH-9496 | Designated Partner | 05 Dec 2016 | 2016 | Strike Off | |
| Rrakov Pharmaceuticals Llp AAK-4992 | Designated Partner | 05 Sep 2017 | 2017 | Strike Off | |
| Snb India Lifestyles Private Limited U70109MH2019PTC330830 | Director | 20 Sep 2019 | 2019 | Strike Off | |
| Shree Gajanan Finance & Investments Private Limited U74999MH2012PTC230567 | Director | 15 Apr 2016 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Roshan Lalchand Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kalpesh Bhavarlal Mehta | 07900180 | Shray Pharma Llp | Designated Partner |
| Kamlesh Harish Jain | 02851812 | Shray Pharma Llp | Designated Partner |
| Rajani Kalpesh Mehta | 07902796 | Shray Pharma Llp | Designated Partner |
| Ritesh Jain Harish | 02613819 | Shray Pharma Llp | Designated Partner |
| Ganesh Sopan Gadge | 06419426 | Rrakov Exim Private Limited , Exemplus Healthcare Private Limited | Director |
| Rajendra Kisanlal Jain | 05250379 | Rrakov Exim Private Limited | Director |
| Sydney Dolrich Fernandes | 10477621 | Ferro Strategic Solutions Private Limited | Director |
| Mahendra Lalchand Jain | 10935773 | Lebron Lifesciences Private Limited | Director |
| Kumarpal Parasmal Oswal | 09362876 | Kera Bella Fashions Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Roshan Lalchand Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Roshan Lalchand Jain
Roshan Lalchand Jain currently holds 6 directorships: Shray Pharma Llp (Designated Partner, since 25 Jul 2019, revenue ₹38.7 Lakh (FY 2022)); Rrakov Exim Private Limited (Director, since 19 Nov 2015); Ferro Strategic Solutions Private Limited (Director, since 23 Jan 2024); Exemplus Healthcare Private Limited (Director, since 02 Jan 2024); Lebron Lifesciences Private Limited (Director, since 26 Dec 2023); and 1 more.
Roshan Lalchand Jain was first appointed on 14 Sep 2015 as Director at Pharex International Private Limited. The most recent appointment on record is 23 Jan 2024 at Ferro Strategic Solutions Private Limited.
Roshan Lalchand Jain held 10 earlier board appointments: Hestco Healthcare Private Limited (Director, 18 Nov 2023 to 28 Jan 2025); Vitalone Pharma Private Limited (Director, 12 Jan 2024 to 28 Jan 2025); Kera Fashions Llp (Designated Partner, 15 Dec 2020 to 02 Dec 2022); Maxwell Life Science Limited (Director, 01 Jan 2019 to 20 Sep 2021); Pharex International Private Limited (Director, 14 Sep 2015 to 31 May 2016); and 5 more.
The current boards of Roshan Lalchand Jain's companies include Kalpesh Bhavarlal Mehta (Shray Pharma Llp), Kamlesh Harish Jain (Shray Pharma Llp), Rajani Kalpesh Mehta (Shray Pharma Llp), Ritesh Jain Harish (Shray Pharma Llp), Ganesh Sopan Gadge (Rrakov Exim Private Limited), Rajendra Kisanlal Jain (Rrakov Exim Private Limited), among others.